BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 22027727)

  • 1. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice?
    Byrne RA; Kastrati A
    EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCI in small vessels: the case for a drug-coated balloon based intervention.
    Zeymer U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-stent restenosis: the gold standard has changed.
    Chin K
    EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
    Bonaventura K; Sonntag S; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
    Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
    Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to use the drug-eluting balloon: recommendations by the German consensus group.
    Kleber FX; Mathey DG; Rittger H; Scheller B;
    EuroIntervention; 2011 May; 7 Suppl K():K125-8. PubMed ID: 22027722
    [No Abstract]   [Full Text] [Related]  

  • 10. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted vascular drug delivery. A new day for an old way.
    Buchbinder M; Solar R
    Panminerva Med; 2013 Dec; 55(4):353-61. PubMed ID: 24434344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventions.
    Cortese B; Danzi GB; Pitì A; Severi S; Limbruno U
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):32-7. PubMed ID: 21413116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New technologies in percutaneous coronary interventions: drug-coated balloons.
    Kleber FX; Scheller B; Serruys PW
    EuroIntervention; 2011 May; 7 Suppl K():K7. PubMed ID: 22027732
    [No Abstract]   [Full Text] [Related]  

  • 14. Local drug delivery for treatment of coronary and peripheral artery disease.
    Gertz ZM; Wilensky RL
    Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevo stent: a successful stent makeover.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
    [No Abstract]   [Full Text] [Related]  

  • 16. From bench to Paccocath.
    Cremers B; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K23-31. PubMed ID: 22027724
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eluting combination drugs from stents.
    Thipparaboina R; Khan W; Domb AJ
    Int J Pharm; 2013 Sep; 454(1):4-10. PubMed ID: 23850234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 20. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
    Abizaid A; Costa JR; Feres F
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):49-51. PubMed ID: 20506126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.